Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lyra Therapeutics, Inc. | Director | Stock Option | 30K | Jun 13, 2024 | Direct | ||
INVIVO THERAPEUTICS HOLDINGS CORP. | Director | Stock Option (right to buy) | 4.2K | Nov 17, 2022 | Direct | ||
Flexion Therapeutics Inc | Director | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | Director | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
LYRA | Lyra Therapeutics, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Director |
LYRA | Lyra Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
LYRA | Lyra Therapeutics, Inc. | Jun 10, 2022 | 1 | $20.2K | 4 | Jun 13, 2022 | Director |
LYRA | Lyra Therapeutics, Inc. | May 13, 2022 | 2 | $18.5K | 4 | May 17, 2022 | Director |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 9 | -$162K | 4 | Nov 19, 2021 | Director |
FLXN | Flexion Therapeutics Inc | Jun 24, 2021 | 2 | $0 | 4 | Jun 28, 2021 | Director |
LYRA | Lyra Therapeutics, Inc. | Jun 17, 2021 | 1 | $31.4K | 4 | Jun 22, 2021 | Director |
LYRA | Lyra Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |